An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy.

Lewis, Sandra J

Lewis, Sandra J.

Affiliation

Lewis SJ; Northwest Cardiovascular Institute, Department of Medicine, Oregon Health and Science University, Portland, USA. sandral@nw-ci.com

J Fam Pract ; 58(11 Suppl Urgent): S32-40, 2009 Nov.

Article in En | MEDLINE | ID: mdl-19891946

Subject(s)

Cholesterol, LDL/blood; Coronary Disease/blood; Coronary Disease/drug therapy; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Biomarkers/blood; Coronary Disease/etiology; Humans; Practice Guidelines as Topic; Risk Factors; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Coronary Disease / Cholesterol, LDL Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Fam Pract Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links